Abstract
This report describes a case of chronic myelomonocytic leukaemia (CMML) in whom a complete remission was achieved and sustained 15 months after treatment with 25-OH vitamin D3. No side-effects were observed. Although vitamin D3 has been used in the treatment of myelodysplastic syndromes, to our knowledge this is the first case of longstanding remission in a patient with CMML. This 'differentiation therapy' might be considered as a possible alternative in the management of this disease.
Original language | English (US) |
---|---|
Pages (from-to) | 811-812 |
Number of pages | 2 |
Journal | British Journal of Haematology |
Volume | 85 |
Issue number | 4 |
DOIs | |
State | Published - Dec 1993 |
All Science Journal Classification (ASJC) codes
- Hematology